These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 31068376)
1. Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition. Kalinski AL; Kar AN; Craver J; Tosolini AP; Sleigh JN; Lee SJ; Hawthorne A; Brito-Vargas P; Miller-Randolph S; Passino R; Shi L; Wong VSC; Picci C; Smith DS; Willis DE; Havton LA; Schiavo G; Giger RJ; Langley B; Twiss JL J Cell Biol; 2019 Jun; 218(6):1871-1890. PubMed ID: 31068376 [TBL] [Abstract][Full Text] [Related]
2. α-Tubulin Acetyltransferase Is a Novel Target Mediating Neurite Growth Inhibitory Effects of Chondroitin Sulfate Proteoglycans and Myelin-Associated Glycoprotein. Wong VSC; Picci C; Swift M; Levinson M; Willis D; Langley B eNeuro; 2018; 5(1):. PubMed ID: 29497702 [TBL] [Abstract][Full Text] [Related]
3. Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Mórotz GM; De Vos KJ; Vagnoni A; Ackerley S; Shaw CE; Miller CC Hum Mol Genet; 2012 May; 21(9):1979-88. PubMed ID: 22258555 [TBL] [Abstract][Full Text] [Related]
4. HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons. Kim C; Choi H; Jung ES; Lee W; Oh S; Jeon NL; Mook-Jung I PLoS One; 2012; 7(8):e42983. PubMed ID: 22937007 [TBL] [Abstract][Full Text] [Related]
5. HDAC6 and Miro1: Another interaction causing trouble in neurons. Van Den Bosch L J Cell Biol; 2019 Jun; 218(6):1769-1770. PubMed ID: 31118238 [TBL] [Abstract][Full Text] [Related]
6. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease. Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205 [TBL] [Abstract][Full Text] [Related]
7. A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice. Onishi T; Maeda R; Terada M; Sato S; Fujii T; Ito M; Hashikami K; Kawamoto T; Tanaka M Sci Rep; 2021 Jul; 11(1):15423. PubMed ID: 34326423 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth. Van Helleputte L; Kater M; Cook DP; Eykens C; Rossaert E; Haeck W; Jaspers T; Geens N; Vanden Berghe P; Gysemans C; Mathieu C; Robberecht W; Van Damme P; Cavaletti G; Jarpe M; Van Den Bosch L Neurobiol Dis; 2018 Mar; 111():59-69. PubMed ID: 29197621 [TBL] [Abstract][Full Text] [Related]
9. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. Misko A; Jiang S; Wegorzewska I; Milbrandt J; Baloh RH J Neurosci; 2010 Mar; 30(12):4232-40. PubMed ID: 20335458 [TBL] [Abstract][Full Text] [Related]